The difference between the major three yangs and the minor three yangs of hepatitis B

Hepatitis B major three positives and small three positives are two different hepatitis B virus infection states, and there are obvious differences between them.

Hepatitis B triple positive means that hepatitis Be antigen, hepatitis B surface antigen and hepatitis B core antibody are simultaneously positive, which usually indicates the complete presence and active replication of hepatitis B virus in the body. Small three yangs refer to hepatitis B surface antigen, hepatitis B e antibodies and hepatitis B core antibodies being positive at the same time. This is often the transformed form of major three yangs, indicating that the virus may be replicating slowly or in a suppressed state.

Hepatitis B virus replication in patients with Da Sanyang is usually more active and the viral load is larger, so they are relatively more contagious. The viral load in patients with Xiaosanyang is generally lower, and the infectivity is correspondingly weakened.

There are also differences in the disease course and staging between major three yang and minor three yang. The carrier state of Da San Yang is usually in the immune tolerance phase, while Da San Yang hepatitis is in the immune clearance phase. In contrast, the carrier state of Xiaosanyang is in the immune control phase, and the Xiaosanyang hepatitis is in the reactivation phase.

Although the symptoms of major three yangs and minor three yangs may vary depending on individual differences, patients with major three yangs may generally experience physical weakness, fatigue, bleeding (such as gum bleeding, nosebleeds, etc.), deepening of jaundice, and digestive tract symptoms (such as anorexia, nausea, vomiting, etc.). Patients with Xiao Sanyang may experience symptoms such as mild fatigue, loss of appetite, liver discomfort, jaundice, and abnormal liver function. It is worth noting that some patients may not have any symptoms, but the virus is still replicating in the body, causing potential damage to the liver.

In addition, for the prevention and control of hepatitis B, in addition to active treatment, comprehensive measures such as strengthening health education, raising awareness of personal hygiene, and avoiding unsafe sexual behaviors should also be implemented. These measures are of great significance in reducing the incidence and transmission risk of hepatitis B.

(Click to view an introduction to drugs for the treatment of hepatitis B.)

References:

https://pesquisa.bvsalud.org/portal/resource/pt/wpr-906637